| Drug-Target Information | ||||||||
|---|---|---|---|---|---|---|---|---|
| Drug Name | Target Name | Drug Type | Target Type | Source | Drug MeSHID | Interaction Score | Drug Status | Target Action |
| mecasermin | insulin-like growth factor 1 receptor | biotech | NA | drugbank , DGIDB | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
10.05 | approved,investigational | agonist |
| mecasermin | insulin-like growth factor i receptor | NA | Successful target | TTD , DGIDB | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
10.05 | approved | unknown |
| mecasermin | insulin-like growth factor i receptor | NA | Successful target | TTD , DGIDB | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
10.05 | approved | agonist |
| mecasermin | cation-independent mannose-6-phosphate receptor | biotech | NA | drugbank | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| mecasermin | insulin-like growth factor-binding protein 3 | biotech | NA | drugbank | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| mecasermin | insulin receptor | biotech | NA | drugbank | Hypothyroidism[MeSHID:D007037] Failure to Thrive[MeSHID:D005183] long-term care[MeSHID:D008134] Neoplasm Metastasis[MeSHID:D009362] Malnutrition[MeSHID:D044342] Gene Deletion[MeSHID:D017353] Disruptive Impulse Control and Conduct Disorders[MeSHID:D007174] |
NA | approved,investigational | unknown |
| click here to return to the previous page | ||||||||